FindTrial
Sign In

Comparison of the effectiveness of cognitive-behavioral therapy and dialectical behavior therapy on emotional dimensions, quality of life, migraine-induced disability, severity of headache and severity of anxiety symptoms in migraine patients with generalized anxiety symptoms

Comparison of the effectiveness of cognitive-behavioral therapy and dialectical behavior therapy on emotional dimensions, quality of life, migraine-induced disability, severity of headache and severity of anxiety symptoms in migraine patients with generalized anxiety symptoms

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180815040797N1
Enrollment
60
Registered
2019-09-08
Start date
2019-09-23
Completion date
Unknown
Last updated
2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Migraine. Condition 2: Generalized Anxiety Disorder. Migraine Generalized anxiety disorder

Interventions

Intervention 1: Intervention group: 16 sessions of 2 hours of dialectical behavioral therapy. Intervention 2: Intervention group: 13 sessions of 2 hours of cognitive-behavioral therapy. Intervention 3

Sponsors

Kashan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Satisfaction of references There is a diagnosis of migraine disorder A score of over 10 in terms of incidence of generalized anxiety disorder Age 40-18 No history of drug use No history of psychotic disorders

Exclusion criteria

Exclusion criteria: Getting Simultaneous Psychotherapy 2 or more absences during psychotherapy sessions Participant's willingness to exit the study Participants with severe psychiatric disorders (psychotic, suicidal ideation, etc.)

Design outcomes

Primary

MeasureTime frame
Disability by headache. Timepoint: Before and after the intervention. Method of measurement: Migraine Disability Scale.;Headache severity. Timepoint: Before and after the intervention. Method of measurement: Migraine Disability Scale.—

Secondary

MeasureTime frame
Quality of Life. Timepoint: Before and after the intervention. Method of measurement: Migraine quality of life questionnaire.;Distress Tolerance. Timepoint: Before and after the intervention. Method of measurement: Before and after the intervention.;Emotion regulation. Timepoint: Before and after the intervention. Method of measurement: Difficulty scale in emotional regulation.;Severity of anxiety symptoms. Timepoint: Before and after the intervention. Method of measurement: The scale of generalizef anxiety disorder 7 questions.—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMina Khalilisafat

Kashan University of Medical Sciences

mina_khalilisefat@yahoo.com+31 55540021

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026